Novel progranulin mutation detected in 2 patients with FTLD

Alzheimer Disease and Associated Disorders

Volumn 25, Issue 2, 2011, Pages 173-178

  Skoglund, Lena ^a   Matsui, Toshifumi ^a   Freeman, Stefanie H ^a   Wallin, Anders ^a   Blom, Elin S ^a   Frosch, Matthew P ^a   Growdon, John H ^a   Hyman, Bradley T ^a   Lannfelt, Lars ^a   Ingelsson, Martin ^a   Glaser, Anna ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

frontotemporal dementia; Frontotemporal lobar degeneration; progranulin; TDP 43; ubiquitin

Indexed keywords

MESSENGER RNA; PROGRANULIN; TAR DNA BINDING PROTEIN; UBIQUITIN;

AGED; ARTICLE; BLUNTED AFFECT; BRAIN CORTEX ATROPHY; BRAIN DEGENERATION; BRAIN PERFUSION; BRAIN SPONGIOSIS; CHROMOSOME ABERRATION; DEMENTIA; DISEASE DURATION; FEMALE; FRAMESHIFT MUTATION; FRONTOTEMPORAL DEMENTIA; GAIT DISORDER; GENE DELETION; GENETIC ANALYSIS; GENETIC SCREENING; GLIOSIS; HAPLOINSUFFICIENCY; HUMAN; HUMAN TISSUE; INCONTINENCE; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MUSCLE HYPERTONIA; MUTATIONAL ANALYSIS; MUTISM; NERVE CELL DEGENERATION; NONSENSE MEDIATED MRNA DECAY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; RNA SPLICING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOP CODON; TREMOR; WHITE MATTER;

AGED; DNA MUTATIONAL ANALYSIS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79958257841     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3181fbc22c     Document Type: Article

References (29)

1. Ratnavalli E, Brayne C, Dawson K, et al. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615-1621. (Pubitemid 34602891)
2. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003;74:1206-1209.
3. Ikeda M, Ishikawa T, Tanabe H. Epidemiology offrontotem-poral lobar degeneration. Dement Geriatr Cogn Disord. 2004; 17:265-268.
4. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
5. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotempo-ral Lobar Degeneration. Acta Neuropathologica. 2007;114:5-22. (Pubitemid 47029055)
6. Taniguchi S, McDonagh AM, Pickering-Brown SM, et al. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein. Neuropathol Appl Neurobiol. 2004;30:1-18. (Pubitemid 38177998)
7. Lipton AM, White CL III, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions pre-dominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl). 2004;108:379-385. (Pubitemid 39462348)
8. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyo-trophic lateral sclerosis. Science. 2006;314:130-133. (Pubitemid 44547757)
9. Stevens M, van Duijn CM, Kamphorst W, et al. Familial aggregation in frontotemporal dementia. Neurology. 1998;50: 1541-1545. (Pubitemid 28283216)
10. Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003;126(Pt 9):2016-2022. (Pubitemid 37059441)
11. Hutton M, Lendon CL, Rizzu P, et al. Association ofmissense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702-705.
12. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol. 1998;43:815-825. (Pubitemid 28280226)
13. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA. 1998;95:7737-7741. (Pubitemid 28293323)
14. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in fronto-temporal dementia. Nat Genet. 2005;37:806-808. (Pubitemid 41077105)
15. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and fronto-temporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377-381. (Pubitemid 38437260)
16. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Muta-tions in progranulin cause tau-negative frontotemporal de-mentia linked to chromosome 17. Nature 2006; 442: 916-919. (Pubitemid 44285946)
17. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920-924. (Pubitemid 44285947)
18. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive fronto-temporal lobar degeneration. Hum Mol Genet. 2006;15: 2988-3001. (Pubitemid 44530703)
19. Gijselinck I, Van Broeckhoven C, Cruts M. Granulin muta-tions associated with frontotemporal lobar degeneration and related disorders: an update. Human Mutation. 2008;29: 1373-1386. (Pubitemid 352774891)
20. Gijselinck I, van der Zee J, Engelborghs S, et al. Progranulin locus deletion in frontotemporal dementia. Hum Mutat. 2008; 29:53-58.
21. Rovelet-Lecrux A, Deramecourt V, Legallic S, et al. Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease. Neurobiology of Disease. 2008;31:41-45.
22. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Research. 2003;31:3 812-3814.
23. Le Ber I, van der Zee J, Hannequin D, et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat. 2007;28:846-855. (Pubitemid 47579934)
24. Pickering-Brown SM, Rollinson S, Du Plessis D, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131(Pt 3):721-731. (Pubitemid 351294717)
25. Mukherjee O, Pastor P, Cairns NJ, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide ofprogranulin. Ann Neurol. 2006;60:314-322. (Pubitemid 44520234)
26. Daniel R, He Z, Carmichael KP, et al. Cellular localization of gene expression for progranulin. J Histochem Cytochem. 2000;48:999-1009. (Pubitemid 30421564)
27. Van Damme P, Van Hoecke A, Lambrechts D, et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol. 2008;181:37-41. (Pubitemid 351519762)
28. Baker CA, Manuelidis L. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA. 2003;100:675-679. (Pubitemid 36126111)
29. Malaspina A, Kaushik N, de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem. 2001; 77:132-145. (Pubitemid 32245087)